Goal management training improves executive control in adults with ADHD: an open trial employing attention network theory to examine effects on attention.

Attention deficit disorder with hyperactivity Cognitive control Cognitive rehabilitation Executive function Treatment

Journal

BMC psychology
ISSN: 2050-7283
Titre abrégé: BMC Psychol
Pays: England
ID NLM: 101627676

Informations de publication

Date de publication:
26 Aug 2022
Historique:
received: 23 06 2021
accepted: 25 07 2022
entrez: 26 8 2022
pubmed: 27 8 2022
medline: 31 8 2022
Statut: epublish

Résumé

Adults with Attention-Deficit/Hyperactivity Disorder (ADHD) typically experience poorer attentional control. According to the attention network theory, attentional control relies on three interacting networks of alerting, orienting, and executive control. In ADHD, it is mainly the alerting and executive control networks that are suggested and found to be compromised. In the current study, we investigated if a group-based metacognitive remediation program (Goal Management Training [GMT]) in adults with ADHD would enhance attentional control using an experimental measure of the attention network theory. We expected that GMT would specifically enhance the executive control and alerting networks. Data from post- and follow up-assessments of 21 adults (age: 39.05 [11.93]) with ADHD who had completed GMT were included. Linear mixed-effects modeling revealed significant improvements in the functioning of the executive control network for the majority of the participants, although a small subset of participants showed a negative development following the intervention. Results also showed an improvement in the orienting network at follow up, but no change in the alerting network. The results may indicate that improvements in the functioning of the executive control network are central to the positive effects of GMT reported in disorders characterized by impaired attentional control. The study was retrospectively registered in the ISRCTN (Identifier: ISRCTN91988877) on the 18/01/2021.

Sections du résumé

BACKGROUND BACKGROUND
Adults with Attention-Deficit/Hyperactivity Disorder (ADHD) typically experience poorer attentional control. According to the attention network theory, attentional control relies on three interacting networks of alerting, orienting, and executive control. In ADHD, it is mainly the alerting and executive control networks that are suggested and found to be compromised.
METHODS METHODS
In the current study, we investigated if a group-based metacognitive remediation program (Goal Management Training [GMT]) in adults with ADHD would enhance attentional control using an experimental measure of the attention network theory. We expected that GMT would specifically enhance the executive control and alerting networks.
RESULTS RESULTS
Data from post- and follow up-assessments of 21 adults (age: 39.05 [11.93]) with ADHD who had completed GMT were included. Linear mixed-effects modeling revealed significant improvements in the functioning of the executive control network for the majority of the participants, although a small subset of participants showed a negative development following the intervention. Results also showed an improvement in the orienting network at follow up, but no change in the alerting network.
CONCLUSION CONCLUSIONS
The results may indicate that improvements in the functioning of the executive control network are central to the positive effects of GMT reported in disorders characterized by impaired attentional control.
TRIAL REGISTRATION BACKGROUND
The study was retrospectively registered in the ISRCTN (Identifier: ISRCTN91988877) on the 18/01/2021.

Identifiants

pubmed: 36028907
doi: 10.1186/s40359-022-00902-9
pii: 10.1186/s40359-022-00902-9
pmc: PMC9414421
doi:

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

207

Informations de copyright

© 2022. The Author(s).

Références

J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Brain Imaging Behav. 2014 Sep;8(3):387-93
pubmed: 22528829
Psychol Med. 2020 Mar;50(4):529-541
pubmed: 32036811
Psychon Bull Rev. 2018 Aug;25(4):1423-1434
pubmed: 29181782
Psychol Med. 2015;45(12):2633-46
pubmed: 26234806
Dev Neuropsychol. 2011;36(5):566-77
pubmed: 21667361
Cereb Cortex. 2016 Oct 1;26(11):4136-4147
pubmed: 27550866
Brain Sci. 2020 Oct 08;10(10):
pubmed: 33050115
J Neurosci. 2013 Apr 17;33(16):7091-8
pubmed: 23595766
J Child Psychol Psychiatry. 2008 Dec;49(12):1339-47
pubmed: 19120713
J Atten Disord. 2019 Jan;23(1):76-86
pubmed: 25555629
J Neurosci Res. 2021 May;99(5):1236-1252
pubmed: 33634892
Front Psychol. 2020 Mar 27;11:388
pubmed: 32292363
J Atten Disord. 2018 Aug;22(10):933-941
pubmed: 25762537
Evid Based Ment Health. 2017 Feb;20(1):4-11
pubmed: 27993933
Behav Res Ther. 2018 Jul;106:47-56
pubmed: 29758392
Neuroimage. 2005 Jun;26(2):471-9
pubmed: 15907304
J Exp Psychol Gen. 2014 Oct;143(5):2020-45
pubmed: 25111580
Psychol Med. 2005 Feb;35(2):245-56
pubmed: 15841682
Am J Psychiatry. 2006 Oct;163(10):1730-8
pubmed: 17012683
Behav Brain Funct. 2008 Feb 12;4:9
pubmed: 18269768
J Consult Clin Psychol. 2004 Oct;72(5):757-66
pubmed: 15482034
Psychiatry Clin Neurosci. 2020 Apr;74(4):257-262
pubmed: 31876024
Neuroimage. 2011 May 1;56(1):290-8
pubmed: 21334442
J Atten Disord. 2017 Nov;21(13):1130-1137
pubmed: 23264370
J Occup Environ Med. 2005 Jun;47(6):565-72
pubmed: 15951716
J Clin Exp Neuropsychol. 1995 May;17(3):416-30
pubmed: 7650103
Am J Psychiatry. 1993 Jun;150(6):885-90
pubmed: 8494063
Hum Brain Mapp. 2014 Apr;35(4):1700-9
pubmed: 23670989
PLoS One. 2019 Jul 25;14(7):e0219472
pubmed: 31344047
Brain Cogn. 2009 Jul;70(2):209-20
pubmed: 19269079
Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14931-6
pubmed: 16192352
J Neurosci Methods. 2016 Dec 1;274:81-93
pubmed: 27720867
Physiol Behav. 2019 Nov 1;211:112657
pubmed: 31445015
J Cogn Neurosci. 2002 Apr 1;14(3):340-7
pubmed: 11970796
Cogn Affect Behav Neurosci. 2007 Jun;7(2):109-19
pubmed: 17672382
J Am Acad Child Adolesc Psychiatry. 2010 Apr;49(4):345-55
pubmed: 20410727
Trends Cogn Sci. 2004 Dec;8(12):539-46
pubmed: 15556023
Annu Rev Neurosci. 1990;13:25-42
pubmed: 2183676
Front Hum Neurosci. 2011 Feb 17;5:9
pubmed: 21369362
Brain Cogn. 2013 Feb;81(1):82-94
pubmed: 23174432
Cortex. 2015 Dec;73:62-72
pubmed: 26363140
Br J Psychiatry. 2009 Mar;194(3):204-11
pubmed: 19252145
Child Adolesc Psychiatr Clin N Am. 2000 Jul;9(3):711-26
pubmed: 10944664
Neuropsychol Rehabil. 2019 Dec;29(10):1569-1599
pubmed: 29540124
Behav Brain Funct. 2011 Jul 27;7:27
pubmed: 21794128
Neurosci Biobehav Rev. 2000 Jan;24(1):3-5
pubmed: 10654653
Psychol Bull. 1997 Jan;121(1):65-94
pubmed: 9000892
Nat Rev Neurosci. 2006 May;7(5):367-79
pubmed: 16760917
J Int Neuropsychol Soc. 2016 Apr;22(4):436-52
pubmed: 26812574
Neurorehabil Neural Repair. 2009 Jun;23(5):468-77
pubmed: 19118131
JAMA Psychiatry. 2013 Feb;70(2):185-98
pubmed: 23247506
Front Psychol. 2018 Nov 29;9:2359
pubmed: 30555383
Nat Rev Dis Primers. 2015 Aug 06;1:15020
pubmed: 27189265
J Int Neuropsychol Soc. 2000 Mar;6(3):299-312
pubmed: 10824502
Neuropsychopharmacology. 2010 Jan;35(1):278-300
pubmed: 19759528
J Clin Psychiatry. 2013 Sep;74(9):902-17
pubmed: 24107764
Front Psychol. 2021 Sep 09;12:659480
pubmed: 34566748
Top Cogn Sci. 2010 Oct;2(4):598-613
pubmed: 25164045
J Atten Disord. 2009 Sep;13(2):175-87
pubmed: 19372500
J Atten Disord. 2011 May;15(4):310-20
pubmed: 20530459
Annu Rev Neurosci. 2012;35:73-89
pubmed: 22524787

Auteurs

Daniel A Jensen (DA)

Department of Biological and Medical Psychology, University of Bergen, Bergen, Norway. Daniel.A.Jensen@uib.no.
Division of Mental Health, Betanien Hospital, Bergen, Norway. Daniel.A.Jensen@uib.no.

Astri J Lundervold (AJ)

Department of Biological and Medical Psychology, University of Bergen, Bergen, Norway.

Jan Stubberud (J)

Department of Psychology, University of Oslo, Oslo, Norway.
Department of Research, Lovisenberg Diaconal Hospital, Oslo, Norway.

Anne Halmøy (A)

Division of Psychiatry, Haukeland University Hospital, Bergen, Norway.
Department of Clinical Medicine, University of Bergen, Bergen, Norway.

Jan Haavik (J)

Division of Psychiatry, Haukeland University Hospital, Bergen, Norway.
Department of Biomedicine, University of Bergen, Bergen, Norway.

Lin Sørensen (L)

Department of Biological and Medical Psychology, University of Bergen, Bergen, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH